94 related articles for article (PubMed ID: 9767908)
21. Bone mineral density after kidney transplantation. A cross-sectional study in 190 graft recipients up to 20 years after transplantation.
Grotz WH; Mundinger FA; Gugel B; Exner VM; Kirste G; Schollmeyer PJ
Transplantation; 1995 Apr; 59(7):982-6. PubMed ID: 7709459
[TBL] [Abstract][Full Text] [Related]
22. A prospective study of bone loss and turnover after cardiac transplantation: effect of calcium supplementation with or without calcitonin.
Välimäki MJ; Kinnunen K; Tähtelä R; Löyttyniemi E; Laitinen K; Mäkelä P; Keto P; Nieminen M
Osteoporos Int; 1999; 10(2):128-36. PubMed ID: 10501793
[TBL] [Abstract][Full Text] [Related]
23. Natural history of mineral metabolism, bone turnover and bone mineral density in de novo renal transplant recipients treated with a steroid minimization immunosuppressive protocol.
Evenepoel P; Claes K; Meijers B; Laurent MR; Bammens B; Naesens M; Sprangers B; Cavalier E; Kuypers D
Nephrol Dial Transplant; 2020 Apr; 35(4):697-705. PubMed ID: 30339234
[TBL] [Abstract][Full Text] [Related]
24. Additional beneficial effects of alendronate in growth hormone (GH)-deficient adults with osteoporosis receiving long-term recombinant human GH replacement therapy: a randomized controlled trial.
Biermasz NR; Hamdy NA; Janssen YJ; Roelfsema F
J Clin Endocrinol Metab; 2001 Jul; 86(7):3079-85. PubMed ID: 11443170
[TBL] [Abstract][Full Text] [Related]
25. Bone loss in long-term renal transplantation: histopathology and densitometry analysis.
Cueto-Manzano AM; Konel S; Hutchison AJ; Crowley V; France MW; Freemont AJ; Adams JE; Mawer B; Gokal R
Kidney Int; 1999 May; 55(5):2021-9. PubMed ID: 10231467
[TBL] [Abstract][Full Text] [Related]
26. [Hemodialysis with 2.5 mEq/L of calcium in relative hypoparathyroidism: long-term effects on bone mass].
Sánchez Perales MC; García Cortés MJ; Borrego FJ; Fernández Martínez S; Borrego J; Pérez del Barrio P; Liébana A; Pérez Bañasco V
Nefrologia; 2000; 20(3):254-61. PubMed ID: 10917002
[TBL] [Abstract][Full Text] [Related]
27. Zoledronic acid to prevent bone loss in the first 6 months after renal transplantation.
Haas M; Leko-Mohr Z; Roschger P; Kletzmayr J; Schwarz C; Mitterbauer C; Steininger R; Grampp S; Klaushofer K; Delling G; Oberbauer R
Kidney Int; 2003 Mar; 63(3):1130-6. PubMed ID: 12631097
[TBL] [Abstract][Full Text] [Related]
28. Long-term effects on bone mineral density of pamidronate given at the time of renal transplantation.
Fan SL; Kumar S; Cunningham J
Kidney Int; 2003 Jun; 63(6):2275-9. PubMed ID: 12753318
[TBL] [Abstract][Full Text] [Related]
29. Effect of calcitriol on bone loss after cardiac or lung transplantation.
Sambrook P; Henderson NK; Keogh A; MacDonald P; Glanville A; Spratt P; Bergin P; Ebeling P; Eisman J
J Bone Miner Res; 2000 Sep; 15(9):1818-24. PubMed ID: 10977001
[TBL] [Abstract][Full Text] [Related]
30. Effects of three immunosuppressive regimens on vertebral bone density in renal transplant recipients: a prospective study.
Aroldi A; Tarantino A; Montagnino G; Cesana B; Cocucci C; Ponticelli C
Transplantation; 1997 Feb; 63(3):380-6. PubMed ID: 9039927
[TBL] [Abstract][Full Text] [Related]
31. Effect of epidural steroid injection on bone mineral density and markers of bone turnover in postmenopausal women.
Al-Shoha A; Rao DS; Schilling J; Peterson E; Mandel S
Spine (Phila Pa 1976); 2012 Dec; 37(25):E1567-71. PubMed ID: 23196966
[TBL] [Abstract][Full Text] [Related]
32. The effect of low-dose cholecalciferol and calcium treatment on posttransplant bone loss in renal transplant patients: a prospective study.
Sahin G; Yasar NS; Sirmagul B; Bal C; Yalcin AU
Ren Fail; 2008; 30(10):992-9. PubMed ID: 19016151
[TBL] [Abstract][Full Text] [Related]
33. Bone loss after renal transplantation: role of hyperparathyroidism, acidosis, cyclosporine and systemic disease.
Heaf J; Tvedegaard E; Kanstrup IL; Fogh-Andersen N
Clin Transplant; 2000 Oct; 14(5):457-63. PubMed ID: 11048990
[TBL] [Abstract][Full Text] [Related]
34. Parathyroid hormone deficiency and excess: similar effects on trabecular bone but differing effects on cortical bone.
Duan Y; De Luca V; Seeman E
J Clin Endocrinol Metab; 1999 Feb; 84(2):718-22. PubMed ID: 10022443
[TBL] [Abstract][Full Text] [Related]
35. Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis.
Mottet JJ; Horber FF; Casez JP; Descoeudres C; Jaeger P
J Bone Miner Res; 1996 Jan; 11(1):96-104. PubMed ID: 8770702
[TBL] [Abstract][Full Text] [Related]
36. Corticosteroid avoidance in adult kidney transplant recipients under rabbit anti-T-lymphocyte globulin, mycophenolate mofetil and delayed cyclosporine microemulsion introduction.
Cantarovich D; Rostaing L; Kamar N; Saint-Hillier Y; Ducloux D; Mourad G; Garrigue V; Wolf P; Ellero B; Cassuto E; Albano L; Soulillou JP;
Transpl Int; 2010 Mar; 23(3):313-24. PubMed ID: 19843296
[TBL] [Abstract][Full Text] [Related]
37. [Changes in mineral metabolism in stage 3, 4, and 5 chronic kidney disease (not on dialysis)].
Lorenzo Sellares V; Torregrosa V
Nefrologia; 2008; 28 Suppl 3():67-78. PubMed ID: 19018742
[TBL] [Abstract][Full Text] [Related]
38. Influence of vitamin D receptor gene polymorphisms on secondary hyperparathyroidism and bone density after kidney transplantation.
Falkiewicz K; Bidzińska B; Demissie M; Boratyńska M; Zmonarski SC; Tworowska K; Klinger M; Milewicz A; Patrzałek D
Transplant Proc; 2005 Mar; 37(2):1023-5. PubMed ID: 15848611
[TBL] [Abstract][Full Text] [Related]
39. Bone loss in pediatric renal transplant recipients.
el-Husseini AA; el-Agroudy AE; Sobh MA; Ghoneim MA
Nefrologia; 2003; 23 Suppl 2():131-4. PubMed ID: 12778870
[TBL] [Abstract][Full Text] [Related]
40. Short-term increases in bone turnover markers predict parathyroid hormone-induced spinal bone mineral density gains in postmenopausal women with glucocorticoid-induced osteoporosis.
Lane NE; Sanchez S; Genant HK; Jenkins DK; Arnaud CD
Osteoporos Int; 2000; 11(5):434-42. PubMed ID: 10912846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
